Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 1.00 |
| ▸ | CYP2C8 | P10632 | 5/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 5/20 | 1.00 |
| ▸ | CYP2B6 | P20813 | 5/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 5/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 4/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.73 |
| ▸ | HTR1A | P08908 | 5/20 | 0.72 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.72 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.72 |
| ▸ | LTA4H | P09960 | 3/20 | 0.72 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.72 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.72 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4877010 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL29711594 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL30417499 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL4881362 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL29371372 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL29801887 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL29805047 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL971599 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL4883880 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 | |
| SCHEMBL17546694 | 0.99 | CYP3A4 (0.97) | CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11602496-B2 | Use of gingerone or derivatives thereof for reducing or delaying the signs of skin ageing | L'OREAL (FR) | 2023-03-14 | — | — | US | disclosed |
| EP-3372220-B1 | USE OF GINGERONE OR DERIVATIVES THEREOF FOR REDUCING OR DELAYING THE SIGNS OF SKIN AGEING | OREAL (FR) | 2019-11-06 | — | — | EP | disclosed |
| EP-3372220-B1 | USE OF GINGERONE OR DERIVATIVES THEREOF FOR REDUCING OR DELAYING THE SIGNS OF SKIN AGEING | OREAL (FR) | 2019-11-06 | — | — | EP | disclosed |
| EP-3372220-A1 | USE OF GINGERONE OR DERIVATIVES THEREOF FOR REDUCING OR DELAYING THE SIGNS OF SKIN AGEING | L'Oréal (FR) | 2018-09-12 | — | — | EP | disclosed |
| US-20180161257-A1 | USE OF GINGERONE OR DERIVATIVES THEREOF FOR REDUCING OR DELAYING THE SIGNS OF SKIN AGEING | L'OREAL (FR) | 2018-06-14 | — | — | US | disclosed |
| US-20180161257-A1 | USE OF GINGERONE OR DERIVATIVES THEREOF FOR REDUCING OR DELAYING THE SIGNS OF SKIN AGEING | L'OREAL (FR) | 2018-06-14 | — | — | US | disclosed |
| US-20180161257-A1 | USE OF GINGERONE OR DERIVATIVES THEREOF FOR REDUCING OR DELAYING THE SIGNS OF SKIN AGEING | L'OREAL (FR) | 2018-06-14 | — | — | US | disclosed |
| EP-2694025-B1 | USE OF ETHYL GINGERONE OR DERIVATIVES THEREOF FOR REDUCING OR DELAYING THE SIGNS OF SKIN AGEING | OREAL (FR) | 2018-04-25 | — | — | EP | disclosed |
| EP-2694025-B1 | USE OF ETHYL GINGERONE OR DERIVATIVES THEREOF FOR REDUCING OR DELAYING THE SIGNS OF SKIN AGEING | OREAL (FR) | 2018-04-25 | — | — | EP | disclosed |
| EP-3281620-A1 | PHOTOPROTECTIVE COMPOSITION BASED ON A 2-ALKOXY-4-ALKYL KETONE PHENOL COMPOUND; USE OF SAID COMPOUND FOR INCREASING THE SUN PROTECTION FACTOR | L'OREAL (FR) | 2018-02-14 | — | — | EP | disclosed |
| US-20120269739-A1 | COMPOSITION, USE, AND PRESERVATION METHOD | L'OREAL (FR) | 2012-10-25 | — | — | US | disclosed |
| US-20120269739-A1 | COMPOSITION, USE, AND PRESERVATION METHOD | L'OREAL (FR) | 2012-10-25 | — | — | US | disclosed |
| US-20120263768-A1 | PHOTOPROTECTIVE COMPOSITION BASED ON A 2-ALKOXY-4-ALKYL KETONE PHENOL COMPOUND; USE OF SAID COMPOUND FOR INCREASING THE SUN PROTECTION FACTOR | L'OREAL (FR) | 2012-10-18 | — | — | US | disclosed |
| US-20120263768-A1 | PHOTOPROTECTIVE COMPOSITION BASED ON A 2-ALKOXY-4-ALKYL KETONE PHENOL COMPOUND; USE OF SAID COMPOUND FOR INCREASING THE SUN PROTECTION FACTOR | L'OREAL (FR) | 2012-10-18 | — | — | US | disclosed |
| WO-2012131072-A1 | USE OF GINGERONE OR DERIVATIVES THEREOF FOR REDUCING OR DELAYING THE SIGNS OF SKIN AGEING | L'OREAL (FR) | 2012-10-04 | — | — | WO | disclosed |
| WO-2012131072-A1 | USE OF GINGERONE OR DERIVATIVES THEREOF FOR REDUCING OR DELAYING THE SIGNS OF SKIN AGEING | L'OREAL (FR) | 2012-10-04 | — | — | WO | disclosed |
| WO-2011042358-A1 | PHOTOPROTECTIVE COMPOSITION BASED ON A 2-ALKOXY-4-ALKYL KETONE PHENOL COMPOUND; USE OF SAID COMPOUND FOR INCREASING THE SUN PROTECTION FACTOR | L'OREAL (FR) | 2011-04-14 | — | — | WO | disclosed |
| WO-2011039444-A2 | COMPOSITION, USE, AND PRESERVATION METHOD | L'OREAL (FR) | 2011-04-07 | — | — | WO | disclosed |
| US-20080038386-A1 | Use of a liquid cooling sensate to provide a pungent, warming or tingling sensate composition | MOZA ASHOK K | 2008-02-14 | — | — | US | disclosed |
| US-4618627-A | ALLERGIES | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1986-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120269739-A1 | COMPOSITION, USE, AND PRESERVATION METHOD | PRKACB, PRKACG, PRKX | CYP3A4 4035/4885CYP2C8 4059/4885CYP2C9 2983/4885 |
| US-11602496-B2 | Use of gingerone or derivatives thereof for reducing or delaying the signs of skin ageing | CYP11B1, AKR1C3, GLA | CYP3A4 282/4885CYP2C8 475/4885CYP2C9 632/4885 |
| US-20180161257-A1 | USE OF GINGERONE OR DERIVATIVES THEREOF FOR REDUCING OR DELAYING THE SIGNS OF SKIN AGEING | CYP11B1, AKR1C3, GLA | CYP3A4 282/4885CYP2C8 475/4885CYP2C9 632/4885 |
| US-20120263768-A1 | PHOTOPROTECTIVE COMPOSITION BASED ON A 2-ALKOXY-4-ALKYL KETONE PHENOL COMPOUND; USE OF SAID COMPOUND FOR INCREASING THE SUN PROTECTION FACTOR | AHR, TYR, CUTA | CYP3A4 707/4885CYP2C8 1367/4885CYP2C9 805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.